Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1987-11-5
|
pubmed:abstractText |
In previous studies and in the accompanying paper, 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP) was found to be more potent than MPTP in producing dopaminergic neurotoxicity in mice. One purpose of the present study was to determine whether 1-methyl-4-(2'-methylphenyl)pyridinium (2'CH3-MPP+), the primary oxidation product of 2'CH3-MPTP both in vivo and in vitro, inhibits mitochondrial respiration as does 1-methyl-4-phenylpyridinium (MPP+), the primary oxidation product of MPTP. Another aim was to determine whether treatments which modify MPTP- and 2'CH3-MPTP-induced neurotoxicity in vivo also cause parallel changes in the metabolic toxicity of these compounds. It was found that 2'CH3-MPP+, like MPP+, inhibited the oxidation of NAD(H)-linked substrates by isolated brain mitochondria in a concentration- and time-dependent manner, whereas succinate oxidation was not affected. Thus, the effect was on Complex I in the electron transport chain. Furthermore, 2'CH3-MPP+, like MPP+, enhanced lactate formation by neostriatal tissue slices as would be expected if Complex respiration were inhibited. MPP+ was slightly more potent than 2'CH3-MPP+ in both of these studies. However, 2'CH3-MPTP was several-fold more potent than MPTP in increasing lactate accumulation by the neostriatal slices. This difference in potency correlated with the differing capacities of 2'CH3-MPTP and MPTP to be oxidized by monoamine oxidase (MAO).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-4-phenyl-1,2,3,6-tetrahydro...,
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-4-phenylpyridinium,
http://linkedlifedata.com/resource/pubmed/chemical/1-methyl-4-(2'-methylphenyl)-1,2,3,6...,
http://linkedlifedata.com/resource/pubmed/chemical/2-(3,4-dimethoxyphenyl)-3-fluoroally...,
http://linkedlifedata.com/resource/pubmed/chemical/Allylamine,
http://linkedlifedata.com/resource/pubmed/chemical/Lactates,
http://linkedlifedata.com/resource/pubmed/chemical/Lactic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridinium Compounds
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
242
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
858-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3498818-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
pubmed-meshheading:3498818-1-Methyl-4-phenylpyridinium,
pubmed-meshheading:3498818-Allylamine,
pubmed-meshheading:3498818-Animals,
pubmed-meshheading:3498818-Brain,
pubmed-meshheading:3498818-Corpus Striatum,
pubmed-meshheading:3498818-Dose-Response Relationship, Drug,
pubmed-meshheading:3498818-Lactates,
pubmed-meshheading:3498818-Lactic Acid,
pubmed-meshheading:3498818-Male,
pubmed-meshheading:3498818-Mice,
pubmed-meshheading:3498818-Mice, Inbred C57BL,
pubmed-meshheading:3498818-Mitochondria,
pubmed-meshheading:3498818-Pyridines,
pubmed-meshheading:3498818-Pyridinium Compounds
|
pubmed:year |
1987
|
pubmed:articleTitle |
Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
|
pubmed:affiliation |
Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|